Its announcement will come within the heels of an identical licensing arrangement made available in February to Adastra Labs, which experienced right up until now focused on crafting cannabis extracts. Adastra's license also permits it to generate and offer psilocybin and psilocin – hallucinogens much more commonly referred to as magic mushrooms